Efficacy and safety of therapies for advanced prostate cancer in Asia: Evidence from a systematic literature review
CONCLUSIONS: This SLR of the Asian data on therapies for advanced PC from the pivotal and real-world studies confirms similar efficacy and safety outcomes, consistent with the results from the pivotal clinical trials. These findings will help clinicians make better treatment decisions in clinical practice for patients with advanced/metastatic PC.PMID:36407784 | PMC:PMC9666834 | DOI:10.1177/17588359221131525
Source: Adv Data - Category: Epidemiology Authors: Marniza Saad Rainy Umbas Edmund Chiong Ravindran Kanesvaran Source Type: research
More News: Abiraterone Acetate | Cancer | Cancer & Oncology | Clinical Trials | Docetaxel | Epidemiology | Prednisone | Prostate Cancer | Study | Taxotere